Victory Capital Management
KNSA icon

Victory Capital Management’s Kiniksa Pharmaceuticals KNSA Stock Holding History

Victory Capital Management’s Portfolio KNSA Stock Details KNSA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$24.4M Sell
506,521
-5,642
-1% -$250K 0.02% 797
2025
Q4 		$21.1M Buy
+512,163
New +$20.5M 0.01% 855
2025
Q3 		– Sell
-58,964
Closed -$1.63M – 2487
2025
Q2 		$1.63M Buy
58,964
+5,647
+11% +$144K ﹤0.01% 1650
2025
Q1 		$1.18M Buy
+53,317
New +$1.1M ﹤0.01% 1730
2024
Q4 		– Sell
-14,902
Closed -$372K – 2505
2024
Q3 		$372K Sell
14,902
-2,441
-14% -$59.5K ﹤0.01% 2086
2024
Q2 		$324K Buy
17,343
+202
+1% +$3.78K ﹤0.01% 2081
2024
Q1 		$338K Buy
17,141
+2,488
+17% +$48.6K ﹤0.01% 2086
2023
Q4 		$257K Buy
14,653
+4,547
+45% +$74.7K ﹤0.01% 2169
2023
Q3 		$176K Buy
+10,106
New +$170K ﹤0.01% 2223
2023
Q1 		– Sell
-65,900
Closed -$987K – 2643
2022
Q4 		$987K Buy
65,900
+14,860
+29% +$216K ﹤0.01% 1745
2022
Q3 		$655K Buy
+51,040
New +$582K ﹤0.01% 1927
2020
Q2 		– Sell
-3,080
Closed -$48K – 2893
2020
Q1 		$48K Buy
+3,080
New +$48.2K ﹤0.01% 2781
2019
Q4 		– Sell
-236,905
Closed -$2.02M – 2956
2019
Q3 		$2.02M Buy
236,905
+158,776
+203% +$1.75M ﹤0.01% 1461
2019
Q2 		$1.06M Sell
78,129
-6,671
-8% -$104K ﹤0.01% 1290
2019
Q1 		$1.53M Sell
84,800
-940
-1% -$18.2K ﹤0.01% 1146
2018
Q4 		$2.41M Sell
85,740
-48,740
-36% -$1.02M 0.01% 992
2018
Q3 		$3.43M Sell
134,480
-7,390
-5% -$144K 0.01% 977
2018
Q2 		$2.46M Buy
+141,870
New +$2.57M 0.01% 1034

Other funds holding KNSA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Victory Capital Management's KNSA Position: Q1 2026 in Review

Victory Capital Management reduced its Kiniksa Pharmaceuticals (KNSA) stake by 1.1% in Q1 2026, selling an estimated $250K and leaving 506,521 shares worth $24.4M. The position accounts for 0.02% of the portfolio, ranked #797.

Victory Capital Management first reported a position in KNSA in Q2 2018 and has held it in 18 quarters since. 228 funds tracked by Wall St. Rank hold KNSA as of Q1 2026.

  • Victory Capital Management held 506,521 shares of Kiniksa Pharmaceuticals worth $24.4M as of Q1 2026.
  • Victory Capital Management sold 5,642 Kiniksa Pharmaceuticals shares in Q1 2026, an estimated $250K.
  • Kiniksa Pharmaceuticals made up 0.02% of Victory Capital Management's portfolio in Q1 2026, its #797 holding.
  • Victory Capital Management first reported a position in Kiniksa Pharmaceuticals in Q2 2018 and has held it in 18 quarters since.
  • 228 funds tracked by Wall St. Rank held Kiniksa Pharmaceuticals as of Q1 2026.

Based on Victory Capital Management's 13F filing for Q1 2026, filed 15 May 2026.